u/Modak-

The pattern is consistent enough to be worth discussing here. A healthcare org builds an early warning model, runs a solid pilot, clears evaluation metrics, gets clinical approval. Then production deployment stalls and the project gets deprioritized six months later.

The MLOps community generally frames this as a model monitoring, drift detection or feature store problem. And those are real. But in healthcare specifically there's a layer underneath all of that which is causing the failure. The data pipeline itself was never designed for execution.

Healthcare data infrastructure defaults to batch processing and retrospective analytics. EHR extracts, normalized stores, warehouses optimized for querying after the fact. That architecture has no concept of execution context. It doesn't know that a particular combination of vitals and medication orders should trigger a model call within a specific clinical workflow before a care decision closes. It just moves data.

What production clinical AI actually requires from the pipeline layer is different from what most MLOps tooling assumes. Governance enforced during execution rather than post-hoc, outputs written back into EHR-native workflows in a way that's auditable and pipeline logic that understands workflow state rather than just data freshness.

The streaming infrastructure problem is largely solved. Kafka, Flink, managed services' latency isn't the hard part anymore. The hard part is the contract between the pipeline and the clinical workflow systems it feeds into.

Has anyone built something in this space that actually made it to production? Curious what the architecture looked like specifically around the EHR writeback problem and how governance was handled at runtime.

Disclosure: We work on data engineering infrastructure for healthcare AI at Modak.

More and more enterprises announce a “Chief AI Officer” lately, and at first glance it feels like the usual title inflation that happens whenever a new technology matures. 

But the more we dig into how AI is actually landing inside large organizations, the more the role starts to make sense. 

Most enterprises today aren’t struggling with whether to use AI. They’re struggling with ownership. 

AI pilots pop up everywhere. Business units experiment. Data teams build models. IT teams worry about infrastructure. Legal and risk teams get involved late. Everyone owns a piece, but no one owns the whole thing. 

The CAIO role isn’t really about “owning models” or running data science teams. It’s about owning AI as a strategic capability across the enterprise. 

Someone who is accountable for: 

• How AI aligns with business priorities 
• How it scales beyond pilots 
• How risk and governance are handled before things break 
• How value is actually realized, not just demoed

 

What’s interesting is that this role isn’t emerging because CIOs, CTOs, or CDOs are failing. It’s emerging because AI cuts across all of their mandates at once. Autonomous agents, regulatory pressure, workforce impact, data sovereignty… none of that fits cleanly into one traditional exec box. 

That said, its also skeptical from an angle. 

Do you already have a de facto CAIO, even if not by title? Do you think this role is a necessary evolution, or a temporary bridge until AI becomes “normal”? 

SRH vs GT : Head-to-Head Data

Since GT entered IPL in 2022:
Total Matches = 6
GT Wins = 4
SRH Wins = 2
GT win rate = 66.7%
SRH win rate = 33.3%

On paper, GT completely own this matchup. Also,GT looks like they found their momentum in the last few matches.

Can SRH break GT in their home ground ? What factors do you think are crucial for today's match?

We are already seeing agents that can write pipeline logic, suggest optimizations, perform transformations, and monitor data quality issues.

If this trend keeps growing, which part of Data Engineering will become completely automated and how will the Data engineer role evolve?

Is anyone here already using AI agents in Production workflows ?

No Messi. No Neymar. No Mbappé.

Less superstar chaos. More actual team football.

Yet somehow this team feels stronger, calmer and more complete than ever before.

Back-to-back UCL finals.

Knocking out Bayern.

Everyone fighting for the badge.

Right now DC is sitting mid-table. To realistically qualify, need 4+ wins from remaining matches and some help from other teams. Winning today match is crucial.

Do you still believe DC can make the playoffs ?

Do IPL teams really use data analytics in real-time decisions?
We always hear about analytics in sports, it’s hard to tell how much of it is actually influencing on-field decisions.

Is it truly data driven or more of a buzzword?

Yes or No what do you think?

When working with AI systems, everything looks fine in small demos.But once you start scaling with real users, larger data and continuous usage, things get messy pretty quickly.

Curious from people who’ve worked on this:

What tends to break first in your experience?
Latency? Costs? Permissions? Data quality? Something else?

Interested in what actually fails under real load vs controlled/demo environments.

LLMs are super helpful but still need to double-check their work.

They can sound confident and still be wrong, especially on edge cases or important stuff, since they generate likely text rather than verified facts

Do you trust them for critical workflows yet or just keep them for low-risk tasks?

with models now writing SQL, building models and generating Insights, what's the defensible core of a data scientist in 3-5 years? Is it domain knowledge, problem framing?
Or are we in denial about how much of the role gets actually automated.

If you’ve been digging into real-time clinical data pipelines, FHIR data pipeline automation, or how to operationalize healthcare AI, you’ve probably hit this wall: everything looks real-time, but nothing actually drives action. Dashboards refresh faster, data flows instantly, yet decisions still lag. So the real question is: is latency actually the problem, or is the system just not built to act?

• Are your pipelines moving data… or enabling decisions at the moment they matter?
• Does FHIR standardization improve access, but stop short of execution?
• Are you optimizing ingestion speed while ignoring workflow context?
• Is “real-time” just faster analytics instead of point-of-care action?
• Can your system decide if it should act now, not just what happened?

Most teams don’t have a speed problem, they have an architecture problem. Until pipelines become execution-aware (AI-native), real-time clinical AI will keep looking good in demos and failing in practice.

Feels like every week there’s a new “next big thing” in AI. Many agents, copilots, fine-tuning, autonomous workflows…

But once you actually try to use them in real workflows, the gap between demo and reality becomes pretty obvious.

Copilots still feel assistive, not truly productive, and agents often need constant supervision.

Curious to hear from people actually building/using this stuff:

• What’s the most overrated part of AI right now?
• And what’s something underrated that’s quietly delivering real value?

For decades, India’s Global Capability Centers were built and optimized for one thing: efficient execution at scale. That model worked when cost and throughput were the primary levers. But AI is changing what enterprises value. The conversation is shifting from “how much work gets done” to “how quickly decisions improve.” The open question is whether GCCs are truly making that transition, or whether the language has moved faster than the operating model.

What seems to be holding many centers in the middle is not talent or intent, but data reality. Senior teams still spend disproportionate time on manual data work, fragmented systems, and late‑stage quality issues. That slows insight, limits trust, and caps strategic ownership. The GCCs that appear to be moving forward are the ones treating speed of insight as a business transition, not a technology upgrade.

Curious if others see this as a real shift underway, or mostly an aspirational narrative so far.